Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods.

Corneli AL, Sorenson JR, Bentley ME, Henderson GE, Bowling JM, Nkhoma J, Moses A, Zulu C, Chilima J, Ahmed Y, Heilig CM, Jamieson DJ, van der Horst C; Breastfeeding, Antiretroviral, and Nutrition Informed Consent Study Group.

AIDS Behav. 2012 Feb;16(2):412-21. doi: 10.1007/s10461-011-9977-z.

2.

Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II) mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic drug valproic acid.

Sylla-Iyarreta Veitía M, Dumas F, Morgant G, Sorenson JR, Frapart Y, Tomas A.

Biochimie. 2009 Oct;91(10):1286-93. doi: 10.1016/j.biochi.2009.06.015. Epub 2009 Jun 27.

PMID:
19563861
3.

Essential metalloelement chelates facilitate repair of radiation injury.

Sorenson JR, Soderberg LS, Chang LW, Walker RB.

Met Based Drugs. 2001;8(4):215-34. doi: 10.1155/MBD.2001.215.

5.

Radioprotectant Activity of 5-Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice.

Kuykendall Iii JA, Simmons Iii H, Irving HJ, Wear MA, Sorenson PG, Tipton LG, Maddox KM, Williams EL, Pham-Tran VA, Credit C, Chowdhury IL, Khan S, Tipton JB, Willingham WM, Sorenson JR.

Met Based Drugs. 1999;6(2):135-41. doi: 10.1155/MBD.1999.135.

6.

Radioprotectant Activity of Dicopper(II) Tetrakis(3,5- Diisopropylsalicylate) and Manganese(II) bis(3,5- Diisopropylsalicylate) Alone and in Combination.

Kuykendall Iii JA, Ebert Ii RH, El-Sayed LH, Roberson PK, Pham-Tran VA, Booth BL, Brooks T, Willingham WM, Sorenson JR.

Met Based Drugs. 1999;6(2):127-34. doi: 10.1155/MBD.1999.127.

7.
9.

Correction: Radioprotectant Activity of 5-Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice.

Kuykendall Iii JA, Simmons Iii H, Irving HJ, Wear MA, Sorenson PG, Tipton LG, Maddox KM, Williams EL, Pham-Tran VA, Credit C, Chowdhury IL, Khan S, Tipton JB, Willingham WM, Sorenson JR.

Met Based Drugs. 1999;6(3):193. doi: 10.1155/MBD.1999.193. No abstract available.

11.

Using formative research to develop a context-specific approach to informed consent for clinical trials.

Corneli AL, Bentley ME, Sorenson JR, Henderson GE, van der Horst C, Moses A, Nkhoma J, Tenthani L, Ahmed Y, Heilig CM, Jamieson DJ.

J Empir Res Hum Res Ethics. 2006 Dec;1(4):45-60. doi: 10.1525/jer.2006.1.4.45.

12.

Prevention of cisplatin-induced kidney epithelial cell apoptosis with a Cu superoxide dismutase-mimetic [copper2II(3,5-ditertiarybutylsalicylate)4(ethanol)4].

Wangila GW, Nagothu KK, Steward R 3rd, Bhatt R, Iyere PA, Willingham WM, Sorenson JR, Shah SV, Portilla D.

Toxicol In Vitro. 2006 Dec;20(8):1300-12.

PMID:
16814979
13.

Development of an interactive computer-assisted instruction (ICAI) program for patient prenatal genetic screening and carrier testing for use in clinical settings.

Griffith JM, Sorenson JR, Jennings-Grant T, Fowler B.

Patient Educ Couns. 2005 Nov;59(2):199-204. Epub 2004 Dec 18.

PMID:
16257626
14.

Assessment of an interactive computer-based patient prenatal genetic screening and testing education tool.

Griffith JM, Sorenson JR, Bowling JM, Jennings-Grant T.

Health Educ Behav. 2005 Oct;32(5):613-26.

PMID:
16148208
15.

Pharmacological and haematological results of rat skin burn injury treatment with Cu(II)2(3,5-diisopropylsalicylate)4.

Malakyan MH, Bajinyan SA, Abrahamyan AK, Petrosyan ZH, Harutyunyan NK, Badiryan VA, Sorenson JR.

Inflammopharmacology. 2004;12(4):321-51.

PMID:
15901413
16.

Assessment of a decision aid to assist genetic testing research participants in the informed consent process.

Sorenson JR, Lakon C, Spinney T, Jennings-Grant T.

Genet Test. 2004 Fall;8(3):336-46.

PMID:
15727260
18.

Pharmacokinetic distribution of 67Cu(II)2[3,5-diisopropyl(carboxy-14C)salicylate]4 among murine tissues.

Blincoe C, Chidambaram M, Salari H, Bond KB, Evans DT, Gray-Kaufman RA, Griffey HB, Tranby SG, Garner-Johnson B, Lee T, Sorenson JR.

Curr Med Chem. 2004 Nov;11(22):3007-15.

PMID:
15544486
19.

Synthesis, crystal structures, and anti-convulsant activities of ternary [Zn(II)(3,5-diisopropylsalicylate)(2)], [Zn(II)(salicylate)(2)] and [Zn(II)(aspirinate)(2)] complexes.

Lemoine P, Viossat B, Dung NH, Tomas A, Morgant G, Greenaway FT, Sorenson JR.

J Inorg Biochem. 2004 Nov;98(11):1734-49.

PMID:
15522401
20.

Racial differences in enrolment in a cancer genetics registry.

Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1349-54.

21.

Low-temperature (180 K) crystal structure, electron paramagnetic resonance spectroscopy, and propitious anticonvulsant activities of CuII2(aspirinate)4(DMF)2 and other CuII2(aspirinate)4 chelates.

Viossat B, Daran JC, Savouret G, Morgant G, Greenaway FT, Dung NH, Pham-Tran VA, Sorenson JR.

J Inorg Biochem. 2003 Aug 1;96(2-3):375-85.

PMID:
12888273
22.

Douglas S Leathar Award.

Sorenson JR.

Health Educ Res. 2003 Apr;18(2):2 p preceding 135. No abstract available.

PMID:
12729172
23.

Communication about carrier testing within hemophilia A families.

Sorenson JR, Jennings-Grant T, Newman J.

Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):3-10.

PMID:
12704632
24.

Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression.

Homoncik M, Jilma B, Donham DC, Frossard M, Keuzer C, Sorenson JR.

Blood Coagul Fibrinolysis. 2003 Feb;14(2):131-8.

PMID:
12632022
25.

Gender differences in psychosocial reactions to cystic fibrosis carrier testing.

Newman JE, Sorenson JR, DeVellis BM, Cheuvront B.

Am J Med Genet. 2002 Nov 22;113(2):151-7.

PMID:
12407705
26.

[Crystallochemistry of copper (II) and zinc (II) chelates by nonsteroidal antiinflammatory drugs].

Viossat B, Morgant G, Sorenson JR, Roch-Arveiller M, Daran JC, Greenaway FT, Nguyen Huy D.

Ann Pharm Fr. 2002 Mar;60(2):102-14. French.

PMID:
11976555
27.
28.

Synthesis, crystal structure, EPR properties, and anti-convulsant activities of binuclear and mononuclear 1,10-phenanthroline and salicylate ternary copper(II) complexes.

Lemoine P, Viossat B, Morgant G, Greenaway FT, Tomas A, Dung NH, Sorenson JR.

J Inorg Biochem. 2002 Apr 10;89(1-2):18-28.

PMID:
11931959
30.
31.
33.

Crystal structure of 180 degree K of bis-3, 5-diisopropylsalicylatobisdimethylsulfoxidozinc(II) and the inhibition of seizures and polymorphonuclear leukocyte chemiluminescence.

Morgant G, Viossat B, Daran JC, Roch-Arveiller M, Giroud JP, Nguyen HD, Sorenson JR.

J Inorg Biochem. 1998 May;70(2):137-43.

PMID:
9666572
34.

Interaction of Cu(II) 3,5-diisopropylsalicylate with human serum albumin--an evaluation of spectroscopic data.

Greenaway FT, Hahn JJ, Xi N, Sorenson JR.

Biometals. 1998 Jan;11(1):21-6.

PMID:
9450314
35.
36.

Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients.

Sorenson JR, Cheuvront B, DeVellis B, Callanan N, Silverman L, Koch G, Sharp T, Fernald G.

Am J Med Genet. 1997 May 16;70(2):121-9.

PMID:
9128929
37.

Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing.

Sorenson JR, Cheuvront B, Bruning A, Talton S, DeVellis B, Koch G, Callanan N, Fernald G.

Am J Med Genet. 1996 Jun 14;63(3):419-25.

PMID:
8737645
38.

Radiation protection and radiation recovery with essential metalloelement chelates.

Sorenson JR, Soderberg LS, Chang LW.

Proc Soc Exp Biol Med. 1995 Dec;210(3):191-204. Review.

PMID:
8539256
40.

Breast-feeding education of obstetrics-gynecology residents and practitioners.

Freed GL, Clark SJ, Cefalo RC, Sorenson JR.

Am J Obstet Gynecol. 1995 Nov;173(5):1607-13.

PMID:
7503208
41.

Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits.

Selby-Harrington M, Sorenson JR, Quade D, Stearns SC, Tesh AS, Donat PL.

Am J Public Health. 1995 Oct;85(10):1412-7.

42.

Breast cancer in African-American families. Risk perception, cancer worry, and screening practices of first-degree relatives.

Royak-Schaler R, deVellis BM, Sorenson JR, Wilson KR, Lannin DR, Emerson JA.

Ann N Y Acad Sci. 1995 Sep 30;768:281-5. No abstract available.

PMID:
8526367
43.

Pediatrician involvement in breast-feeding promotion: a national study of residents and practitioners.

Freed GL, Clark SJ, Lohr JA, Sorenson JR.

Pediatrics. 1995 Sep;96(3 Pt 1):490-4.

PMID:
7651783
44.

Translating research into MCH service: comparison of a pilot project and a large-scale resource mothers program.

Rogers MM, Peoples-Sheps MD, Sorenson JR.

Public Health Rep. 1995 Sep-Oct;110(5):563-9; discussion 562.

45.

CF carrier testing: Experience of relatives.

Callanan NP, Bloom D, Sorenson JR, Devellis BM, Cheuvront B.

J Genet Couns. 1995 Jun;4(2):83-95. doi: 10.1007/BF01408632.

PMID:
24234307
46.

Modulation of polymorphonuclear leukocyte responsiveness by copper (II)2 (niflumate)4.

Roch-Arveiller M, Maman L, Huy DP, Fontagne J, Giroud JP, Sorenson JR.

Inflamm Res. 1995 May;44(5):198-203.

PMID:
7655993
47.

Breast-feeding education and practice in family medicine.

Freed GL, Clark SJ, Curtis P, Sorenson JR.

J Fam Pract. 1995 Mar;40(3):263-9.

PMID:
7876784
48.

Anticonvulsant properties of copper acetazolamide complexes.

Alzuet G, Ferrer S, Borrás J, Sorenson JR.

J Inorg Biochem. 1994 Aug 1;55(2):147-51.

PMID:
8051542
49.

The Human Genome Project and health behavior and health education research.

Sorenson JR, Cheuvront B.

Health Educ Res. 1993 Dec;8(4):589-93.

PMID:
10146565
50.

Radiorecovery activity of manganese(III)2(II)(mu 3-O)-(mu-3,5-diisopropylsalicylate)6.

Henderson TD, Burt RL, Kaufman SE, Willingham WM, Sorenson JR.

Radiat Res. 1993 Oct;136(1):126-9.

PMID:
8210328

Supplemental Content

Loading ...
Support Center